12 Results (showing 1 - 10)
FindHelp.org, previously known as Aunt Bertha, is a website designed to help identify and search for free or reduced cost services like medical care, food, job training, and more. User enters zip code to search for these services in their area.
This article characterizes the opioid epidemic is a crisis of disrupted parental attachment. Children who have parents with substance use disorders need healthy attachment bonds with their primary adult caregiver in order to grow, develop, and thrive. Foster care is a crucial therapeutic intervention that can address this need while helping to ensure the child’s safety and wellbeing but is not the only way. Family First embraces the core principle of avoiding unnecessary foster care by addressing the needs of families in crisis.
The American Indian experience of historical trauma is thought of as both a source of intergenerational trauma responses as well as a potential causative factor for long-term distress and substance abuse among communities. The aims of this study were to evaluate the extent to which the frequency of thoughts of historical loss and associated symptoms are influenced by: current traumatic events, post-traumatic stress disorder (PTSD), cultural identification, percent Native American Heritage, substance dependence, affective/anxiety disorders, and conduct disorder/antisocial personality disorder (ASPD).
Using the Program Sustainability Assessment Tool to Assess and Plan for sustainability.
Using data from the National Survey of Child and Adolescent Well-Being II (NSCAW II), this article examines the impact of caregiver substance abuse on children’s exposure to violence in the home in a nationally representative sample of families involved with child protective services (CPS). Logistic regression analyses indicate an increased risk of witnessing mild and severe violence in the home for children whose primary caregiver was abusing alcohol or drugs.
Many families become involved in the child welfare system due to substance use-related safety and parenting concerns. This issue of CW360° features a partnership with the Minnesota Center for Chemical and Mental Health and explores the impact and implications of families’ co-occurring involvement in the child welfare and substance use disorder treatment systems and work at the local, state, and federal levels to support families.
This AAP clinical report reviews some of the short-term effects of maternal substance use during pregnancy and long-term implications of fetal exposure inclduing medical, psychiatric, and behavioral symptoms of children and adolescents in families affected by substance use.It provides suggestions for pediatricians, including screening families, mandated reporting requirements, and directing families to services.
National experience demonstrates that prevention initiatives have contributed to past or ongoing reductions in cocaine use, underage drinking, and youth cigarette smoking. Identifying evidence-based preventive measures for opioids remains a work-in progress that will require more documentation of how prevention strategies can best ameliorate the current crisis. This article presents an update and makes the case for more research, evaluation and community-based prevention.
At least one trauma is reported by two-thirds of American children and adolescents (hereafter referred to as “children”); 33% of children experience multiple traumas before reaching adulthood. Although most children are resilient, trauma exposure is associated with increased risk for medical and mental health problems including Posttraumatic Stress Disorder (PTSD), depression, anxiety, substance abuse, and attempted and completed suicide. Core TF-CBT principles are 1) phase- and components-based treatment; 2) component order and proportionality of phases; 3) the use of gradual exposure in TF-CBT and 4) the importance of integrally including parents or other primary caregivers into TF-CBT treatment.
While randomized clinical trials (RCTs) should provide the basis for evidence based medicine, as currently designed and analyzed, they often mislead clinical decision-making. Comparative effectiveness evaluation of two treatments [Treatment 1 (T1) versus Treatment 2 (T2)] should not be determined by the statistical effect of treatments on individual measures of outcome (benefits and/or harms), but rather on the clinical effects of treatments on individual patients who can experience both benefits and harms. This article discusses strategies to solve this complex issue.